Chemed (CHE) Change in Accured Expenses (2009 - 2026)

Chemed's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $6.7 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 605.47% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $16.2 million (up 56.08% YoY), while the FY2025 annual figure was $10.4 million, down 54.18% from the prior year.
• Change in Accured Expenses was $6.7 million for Q1 2026 at Chemed, up from $4.1 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $13.3 million in Q1 2024 to a low of -$5.1 million in Q3 2022.
• Historically, Change in Accured Expenses has averaged $2.9 million across 5 years, with a median of $3.0 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Change in Accured Expenses sank 249.56% in 2022, then soared 605.47% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at $3.2 million in 2022, then plunged by 57.07% to $1.4 million in 2023, then surged by 219.84% to $4.4 million in 2024, then declined by 7.54% to $4.1 million in 2025, then surged by 64.88% to $6.7 million in 2026.
• The last three Change in Accured Expenses figures came in at $6.7 million (Q1 2026), $4.1 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.